A performance/cost model for a CUDA drug discovery application on physical and public cloud infrastructures
Ginés D. Guerrero(Universidad de Murcia), Horacio Pérez‐Sánchez(Universidad Católica de Murcia), Daniel Mozos(Universidad Complutense de Madrid), José Luis Vázquez‐Poletti(Universidad Complutense de Madrid), José M. Cecilia(Universitat Politècnica de València), José M. Garcı́a(Universidad de Murcia), Richard M. Wallace(Universidad Complutense de Madrid)
Cited by 14
Related Papers
MCC950 closes the active conformation of NLRP3 to an inactive state
|Nature Chemical Biology|2019|446
Neural network and deep-learning algorithms used in QSAR studies: merits and drawbacks
|Drug Discovery Today|2018|224
A Comprehensive Docking and MM/GBSA Rescoring Study of Ligand Recognition upon Binding Antithrombin
|Current Topics in Medicinal Chemistry|2017|193
High-Throughput parallel blind Virtual Screening using BINDSURF
|BMC Bioinformatics|2012|190
Managing, Analysing, and Integrating Big Data in Medical Bioinformatics: Open Problems and Future Perspectives
|BioMed Research International|2014|175